Contact Oxy Watchdog
Send comments to Erin Marie Daly at oxywatchdog@gmail.com.Follow Oxy Watchdog
Oxy Watchdog’s Story
Subscribe To Our Newsletter
Find It
Hear It
Watch It
Hot Topics
addiction Big Pharma Crime DEA Deaths doctors doctor shopping drug monitoring program education FDA heroin hydrocodone methadone narcotics OP Opana opiates opioid overdose overdoses oxy oxy-to-heroin oxycodone OxyContin pain clinics painkillers pain medication Percocet pharmaceutical pharmacy pill mills pills politics prescription drug abuse prescription drug monitoring program Prescription Drug Take-Back Day prescriptions Purdue Pharma robberies Roxycodone Schedule II narcotics Teen deaths Vicodin withdraw XanaxBlogroll
Resources
- Alliance of States with Prescription Monitoring Programs
- CASA Columbia
- Dispose My Meds
- Drugwatch.com
- Faces & Voices of Recovery
- Henry's Fund
- Narcotics Overdose Prevention and Education (NOPE Task Force)
- National Coalition Against Prescription Drug Abuse
- NIDA – Commonly Abused Prescription Drugs
- Office of National Drug Control Policy – Prescription Drug Abuse
- S.O.L.A.C.E. – Surviving Our Loss with Awareness, Compassion & Empathy
- SAMHSA
- Save A Star Drug Awareness Foundation
- Stop Drug Death
- TeensHealth – Prescription Drug Abuse
- The 11 Most Abused Prescription Drugs
- The Medicine Abuse Project
- Time To Talk
- Treatment4Addiction
Categories
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
Author Archives: Erin Marie Daly
Opiate abuse epidemic prompts new N.C. inpatient center
North Carolina is set to open a new inpatient treatment center specifically to deal with the state’s growing problem with opioid addiction, according to this article. The Walter B. Jones Alcohol and Drug Abuse Treatment Center in Greenville, N.C. has been certified by the federal government to become the state’s only inpatient center, and will be one of 75 nationwide offering full services for opiate addiction.
The program will serve high-risk patients with intake, detoxification and treatment in a hospital setting, and will also offer services to new mothers, who can bring children under age one into treatment with them, the article says.
Last year, about 1,000 people in North Carolina died of prescription drug overdoses, according to the N.C. Attorney General’s Office.
Posted in Informational, Trends
Tagged addiction, Deaths, heroin, narcotics, North Carolina, opiates, oxy, oxycodone, OxyContin, pain medication, painkillers, prescription drug abuse, Schedule II narcotics, treatment, withdraw
Leave a comment
Minn. medical group wants MDs to take action
The Minnesota Medical Association is considering requiring doctors to take continuing education courses on pain management and addiction and increasing use of the Minnesota Prescription Monitoring Program in order to deal with the state’s prescription drug abuse issue, according to this article. As of March 2013, only 40% of pharmacists and 30% of doctors in Minnesota were using the monitoring system, according to the article.
Posted in Informational, Policy & Regulation, Trends
Tagged addiction, doctor shopping, doctors, drug monitoring program, education, Minnesota, Minnesota Medical Association, narcotics, opiates, OxyContin, pain clinics, pain medication, painkillers, pharmaceutical, pharmacy, pill mills, pills, prescription drug abuse, prescription drug monitoring database, Schedule II narcotics
1 Comment
Heroin deaths surge in Fla. following pill crackdown
Florida has taken a number of measures to combat its prescription drug addiction problem, with the unintended consequence of the resurgence of heroin as a popular substitute for painkillers. From July 2010 to June 2011, there were 45 heroin-related deaths statewide, according to this article, which cites data from the Florida Medical Examiners Commission. That number jumped to 77 heroin-related deaths from July 2011 to June 2012, the article says.
The article also notes that addiction treatment numbers are up in Florida, with treatment centers in Broward County seeing an 87% increase in admissions in 2012 among addicts using heroin as their drug of choice, up from 169 to 316; in Miami-Dade County, such admissions jumped from 227 to 308 in the first half of 2012.
It was reported earlier this year that while the number of oxycodone-related deaths in Florida plunged during the first half of 2012 compared with the same period in 2011, heroin-related deaths were holding steady.
Florida’s crackdown on painkiller abuse has resulted in the number of pill mills in the state dropping from 854 to 580 between March 2011 and March 2012, according to this article.
Generic Opana to remain on the market: FDA
The U.S. Food and Drug Administration said Friday it will continue to allow sales of the generic version of the painkiller Opana that does not include an abuse-resistant feature.
Opana’s manufacturer, Endo Pharmaceuticals, had submitted a petition to the agency asking it to ban generic forms of the painkiller, which Endo has reformulated as “Opana ER” to make it harder to abuse. That petition was denied by the FDA, which said Endo’s reformulation was not significantly safer than the original version:
While there is an increased ability of the reformulated version of Opana ER to resist crushing relative to the original formulation, study data show that the reformulated version’s extended-release features can be compromised when subjected to other forms of manipulation, such as cutting, grinding, or chewing, followed by swallowing. Reformulated Opana ER can be readily prepared for injection, despite Endo’s claim that these tablets have “resistance to aqueous extraction (i.e., poor syringeability).” It also appears that reformulated Opana ER can be prepared for snorting using commonly available tools and methods.
Endo’s petition came after Purdue Pharma successfully asked the FDA to ban any generic versions of OxyContin based on the powerful painkiller’s original formulation, which does not include anti-abuse features designed to make it more difficult to crush, break, or dissolve.
Posted in Informational, Pharmaceutical Industry, Policy & Regulation
Tagged addiction, Big Pharma, Endo Pharmaceuticals, FDA, narcotics, OP, Opana, Opana ER, opioid, oxy, oxycodone, OxyContin, pain medication, painkillers, pills, politics, prescription drug abuse, Purdue Pharma, Schedule II narcotics
Leave a comment
Heroin addiction vaccine on the horizon?
Scientists are developing a vaccine to treat heroin addiction, and it has proven effective in keeping drug-addicted rats from relapsing in a preclinical trial, according to this article in Popular Science. Researchers from the Scripps Research Institute in California revealed in a study published in Proceedings of the National Academy of Sciences that the vaccine is now ready for human trials.
The vaccine apparently generates antibodies that bind heroin and its metabolites in the bloodstream, preventing them from making their way to the brain. The vaccine “essentially keeps the body from experiencing the fun parts of drug use, like euphoria and pain obstruction,” the article says.
According to the article:
In the study, rats were trained to press a lever three times to receive an injection of heroin. During 12-hour periods of self-administrated access to the drug, the addicted rats began taking heroin compulsively in greater and greater quantities. Then the researchers removed the heroin for 30 days and gave some of the rats the vaccine. After the period of abstention, they were re-exposed to freely accessible heroin. Rats that didn’t receive the treatment resumed taking the drug in increasing quantities, while those that received the treatment didn’t redevelop the compulsion.
Posted in Informational
Tagged addiction, heroin, opiates, Schedule II narcotics, scientists, vaccine
Leave a comment
N.J. county sees heroin ODs skyrocket
In New Jersey, where drug overdoses are the leading cause of accidental death, one county is experiencing a massive uptick in heroin overdoses as prescription painkiller addicts make the switch to the illegal street drug. In two years, heroin has claimed at least 50 lives in Bergen County and has its grasp on hundreds more who became hooked through painkillers such as OxyContin and Opana, according to this article. As compared to pills, heroin, at $5 per bag, is far cheaper, potent, and widely available, the article notes.
The widespread painkiller addiction epidemic has fueled the rise of heroin use nationwide, particularly among suburban youth. Between 2007 and 2011, the number of users went from 373,000 to 620,000, according to federal data, and heroin-dependent young adults more than doubled to 109,000 between 2009 and 2011, according to the article.
Legislators in New Jersey are currently considering implementing a law that would grant immunity to those who dispense and administer naloxone, a medication that counters the effects of overdoses from opiates like OxyContin and heroin. The Opioid Antidote and Overdose Prevention Act would allow medical providers to prescribe naloxone and allow people to administer the drug to overdose victims without fear of being prosecuted. It would also require that prescription recipients get information on how to prevent and recognize overdoses, as well as how to administer the medication and care for the overdose victim. Eight other states have similar laws.
Painkiller market to reach $8.4B by 2017: WSJ
Prescription painkiller sales are set to increase by 15% and hit $8.4 billion by 2017, due in part to the U.S. Food and Drug Administration’s recent decision to ban any generic versions of OxyContin based on the powerful painkiller’s original formulation, which does not include anti-abuse features designed to make the pill harder to abuse. Experts are predicting a race across the pharmaceutical industry to create a market where all opioids have abuse-deterrent properties, according to the Wall Street Journal.
According to the FDA, “because original OxyContin provides the same therapeutic benefits as reformulated OxyContin, but poses an increased potential for certain types of abuse, the FDA has determined that the benefits of original OxyContin no longer outweigh its risks and that original OxyContin was withdrawn from sale for reasons of safety or effectiveness.”
OxyContin’s manufacturer, Purdue Pharma, reformulated the drug in 2010 to make it more difficult to crush, break, or dissolve; the reformulated pill forms a viscous hydrogel and cannot be easily prepared for injection. The FDA noted Tuesday that abuse of OxyContin by these routes, as well as the oral route, is still possible.
Posted in Informational, Pharmaceutical Industry, Policy & Regulation, Trends
Tagged addiction, Big Pharma, FDA, hydrocodone, narcotics, Opana, opiates, oxy, oxycodone, OxyContin, pain medication, painkillers, pills, politics, prescription drug abuse, Purdue Pharma, Roxycodone, Schedule II narcotics, Vicodin, Xanax
1 Comment
Painkiller abuse drives heroin ODs in Maine
Like many other areas that have struggled with prescription drug abuse, Maine is now seeing a dramatic spike in heroin overdoses as pill addicts make the switch to the illegal street drug. Portland city officials say that in the past month, they have responded to 14 reports of overdoses, and there have been three deaths from possible overdoses, according to this article.
On Wednesday alone, the Portland Fire Department provided emergency life-saving medical treatment to four people who had overdosed on heroin, while a fifth person was found dead in an apartment from a possible drug overdose, the article says.
One huge factor behind the switch to heroin is the reformulation of OxyContin, one of the most commonly abused painkillers.
The most recent National Survey on Drug Use and Health found that heroin use has risen to 239,000 users in 2010 from 213,000 in 2008 – likely as a result of painkiller addicts switching to the street drug.
Awareness of ‘Good Samaritan’ laws still lacking
As of March 2013, drug overdose “Good Samaritan” laws were in effect in 10 states and the District of Columbia, and were being actively considered by at least a half-dozen state legislatures. But many people are unaware of these laws, or are still fearful of being arrested if they call for help for overdose victims, anecdotal evidence shows. For example, this article out of Chicago reports that in one county, 175 people have died of heroin overdoses since 2007. In many of those cases, the article says, the victims were surrounded by people when they overdosed, but no one called 911 for help – even though Illinois passed a Good Samaritan law last year.
Good Samaritan laws typically provide immunity from drug possession charges; immunity applies to a person who seeks medical aid during an overdose (for example, by calling 911 or taking someone to the ER), and to a person having an overdose.
Even though opiate overdoses are on the rise, many people don’t call 911 out of fear of arrest and prosecution, and instead rely on ineffective methods of reviving victims.
Painkiller abuse among the elderly on the rise
Although prescription drug addiction is often portrayed as an issue affecting teens and young adults, America’s 78 million aging baby boomers are also experiencing the effects of the epidemic, according to this article in the New York Times. A 2011 study by the Substance Abuse and Mental Health Services Administration found that among adults aged 50 to 59, the rate of current illicit drug use increased to 6.3% in 2011 from 2.7% in 2002; opiates were among the most commonly abused drugs, the article says.
Other studies have estimated that up to 10% of the elderly misuse prescription drugs with major abuse potential, most often anti-anxiety benzodiazepines like Klonopin, sleeping aids like Ambien, and opiate painkillers such as OxyContin, the article says. In addition, women far outnumber men when it comes to nonmedical use of prescription medication: 44% of women as opposed to 23% of men, according to SAMHSA.
One major generational difference seems to be that the elderly rarely use alcohol or drugs to “get high” — rather, they turn to alcohol and drugs in response to the physical and psychological pain due to medical and psychiatric illness, the loss of loved ones, or social isolation, the article notes.
Posted in Informational, Surveys & Statistics, Trends
Tagged addiction, aging, Ambien, American Academy of Addiction Psychiatry, Deaths, elderly, hydrocodone, Klonopin, narcotics, New York Times, opiates, opioid, oxycodone, OxyContin, pain medication, painkillers, pharmaceutical, pills, prescription drug abuse, prescriptions, Schedule II narcotics, Vicodin, Xanax
Leave a comment
